159 related items for PubMed ID: 35781728
1. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.
Lawrence N, Bacila I, Dawson J, Bryce J, Ali SR, van den Akker ELT, Bachega TASS, Baronio F, Birkebaek NH, Bonfig W, van der Grinten HC, Costa EC, de Vries L, Elsedfy H, Güven A, Hannema S, Iotova V, van der Kamp HJ, Clemente M, Lichiardopol CR, Milenkovic T, Neumann U, Nordenström A, Poyrazoğlu Ş, Probst-Scheidegger U, De Sanctis L, Tadokoro-Cuccaro R, Thankamony A, Vieites A, Yavaş Z, Faisal Ahmed S, Krone N.
Clin Endocrinol (Oxf); 2022 Nov; 97(5):551-561. PubMed ID: 35781728
[Abstract] [Full Text] [Related]
2. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia.
de Groot MJ, Pijnenburg-Kleizen KJ, Thomas CM, Sweep FC, Stikkelbroeck NM, Otten BJ, Claahsen-van der Grinten HL.
Clin Chem Lab Med; 2015 Feb; 53(3):461-8. PubMed ID: 25283138
[Abstract] [Full Text] [Related]
3. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
4. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
Tschaidse L, Reisch N, Arlt W, Brac de la Perriere A, Linden Hirschberg A, Juul A, Mallappa A, Merke DP, Newell-Price JDC, Perry CG, Prete A, Rees DA, Stikkelbroeck NMML, Touraine PA, Coope H, Porter J, Ross RJM, Quinkler M.
Eur J Endocrinol; 2023 Jan 10; 188(1):. PubMed ID: 36654495
[Abstract] [Full Text] [Related]
5. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
[Abstract] [Full Text] [Related]
6. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Gröschl M, Rauh M, Dörr HG.
J Clin Endocrinol Metab; 2002 Mar 06; 87(3):1200-4. PubMed ID: 11889188
[Abstract] [Full Text] [Related]
7. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M.
Clin Endocrinol (Oxf); 1995 Mar 06; 42(3):265-72. PubMed ID: 7758231
[Abstract] [Full Text] [Related]
8. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kang MJ, Kim SM, Lee YA, Shin CH, Yang SW.
J Korean Med Sci; 2011 Nov 06; 26(11):1454-60. PubMed ID: 22065901
[Abstract] [Full Text] [Related]
9. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL.
Horm Res Paediatr; 2019 Nov 06; 91(6):416-420. PubMed ID: 31450227
[Abstract] [Full Text] [Related]
10. Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.
Schröder MAM, van Herwaarden AE, Span PN, van den Akker ELT, Bocca G, Hannema SE, van der Kamp HJ, de Kort SWK, Mooij CF, Schott DA, Straetemans S, van Tellingen V, van der Velden JA, Sweep FCGJ, Claahsen-van der Grinten HL.
J Clin Endocrinol Metab; 2022 Mar 24; 107(4):e1661-e1672. PubMed ID: 34788830
[Abstract] [Full Text] [Related]
11. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
12. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M, Mallappa A, Gounden V, Nella AA, Harrison RF, Crutchfield CA, Backlund PS, Soldin SJ, Ross RJ, Merke DP.
Eur J Endocrinol; 2015 Dec 25; 173(6):727-37. PubMed ID: 26340969
[Abstract] [Full Text] [Related]
13. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
Sahlander F, Bensing S, Falhammar H.
Front Endocrinol (Lausanne); 2022 Dec 25; 13():1017303. PubMed ID: 36545328
[Abstract] [Full Text] [Related]
14. An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia.
Al-Kofahi M, Ahmed MA, Jaber MM, Tran TN, Willis BA, Zimmerman CL, Gonzalez-Bolanos MT, Brundage RC, Sarafoglou K.
Br J Clin Pharmacol; 2021 Mar 25; 87(3):1098-1110. PubMed ID: 32652643
[Abstract] [Full Text] [Related]
15. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
Hughes IA, Read GF.
Horm Res; 1984 Mar 25; 19(2):77-85. PubMed ID: 6538545
[Abstract] [Full Text] [Related]
16. Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Merke DP, Mallappa A, Arlt W, Brac de la Perriere A, Lindén Hirschberg A, Juul A, Newell-Price J, Perry CG, Prete A, Rees DA, Reisch N, Stikkelbroeck N, Touraine P, Maltby K, Treasure FP, Porter J, Ross RJ.
J Clin Endocrinol Metab; 2021 Apr 23; 106(5):e2063-e2077. PubMed ID: 33527139
[Abstract] [Full Text] [Related]
17. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH.
J Clin Endocrinol Metab; 2022 Feb 17; 107(3):801-812. PubMed ID: 34653252
[Abstract] [Full Text] [Related]
18. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
Magnisali P, Chalioti MB, Livadara T, Mataragas M, Paliatsiou S, Malamitsi-Puchner A, Moutsatsou P.
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun 01; 879(19):1565-72. PubMed ID: 21514253
[Abstract] [Full Text] [Related]
19. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
Bacila I, Freeman N, Daniel E, Sandrk M, Bryce J, Ali SR, Yavas Abali Z, Atapattu N, Bachega TA, Balsamo A, Birkebæk N, Blankenstein O, Bonfig W, Cools M, Costa EC, Darendeliler F, Einaudi S, Elsedfy HH, Finken M, Gevers E, Claahsen-van der Grinten HL, Guran T, Güven A, Hannema SE, Higham CE, Iotova V, van der Kamp HJ, Korbonits M, Krone RE, Lichiardopol C, Luczay A, Mendonca BB, Milenkovic T, Miranda MC, Mohnike K, Neumann U, Ortolano R, Poyrazoglu S, Thankamony A, Tomlinson JW, Vieites A, de Vries L, Ahmed SF, Ross RJ, Krone NP.
Eur J Endocrinol; 2021 Apr 01; 184(4):553-563. PubMed ID: 33460392
[Abstract] [Full Text] [Related]
20. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE.
J Clin Endocrinol Metab; 2006 Jun 01; 91(6):2179-84. PubMed ID: 16551734
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
